These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

954 related items for PubMed ID: 9544991

  • 1. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 2. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N, Matsuda T.
    J Biol Chem; 2000 Dec 15; 275(50):39718-26. PubMed ID: 10993888
    [Abstract] [Full Text] [Related]

  • 3. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G.
    Mol Endocrinol; 2001 Nov 15; 15(11):1941-52. PubMed ID: 11682625
    [Abstract] [Full Text] [Related]

  • 4. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
    Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S.
    J Biol Chem; 2002 Aug 23; 277(34):31107-14. PubMed ID: 12060651
    [Abstract] [Full Text] [Related]

  • 5. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
    Miquet JG, Sotelo AI, Bartke A, Turyn D.
    Endocrinology; 2004 Jun 23; 145(6):2824-32. PubMed ID: 15016718
    [Abstract] [Full Text] [Related]

  • 6. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
    Ali S, Nouhi Z, Chughtai N, Ali S.
    J Biol Chem; 2003 Dec 26; 278(52):52021-31. PubMed ID: 14522994
    [Abstract] [Full Text] [Related]

  • 7. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P, Zadeh MM, Rottapel R, Lebrun JJ, Ali S.
    Blood; 2004 Feb 15; 103(4):1398-407. PubMed ID: 14551136
    [Abstract] [Full Text] [Related]

  • 8. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O, Daniel N, Bignon C, Jolivet G, Djiane J.
    Mol Cell Endocrinol; 1997 Mar 28; 127(2):155-69. PubMed ID: 9099911
    [Abstract] [Full Text] [Related]

  • 9. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
    Ali S, Ali S.
    J Biol Chem; 1998 Mar 27; 273(13):7709-16. PubMed ID: 9516478
    [Abstract] [Full Text] [Related]

  • 10. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
    Horsch K, Schaller MD, Hynes NE.
    Mol Endocrinol; 2001 Dec 27; 15(12):2182-96. PubMed ID: 11731619
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C, Susini C, Melmed S.
    J Clin Invest; 1999 Nov 27; 104(9):1277-85. PubMed ID: 10545526
    [Abstract] [Full Text] [Related]

  • 12. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H.
    J Am Soc Nephrol; 2004 Dec 27; 15(12):3215-24. PubMed ID: 15579525
    [Abstract] [Full Text] [Related]

  • 13. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL, Richards JS.
    Mol Endocrinol; 1999 Dec 27; 13(12):2049-64. PubMed ID: 10598581
    [Abstract] [Full Text] [Related]

  • 14. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A.
    J Biochem; 2003 Jan 27; 133(1):109-13. PubMed ID: 12761205
    [Abstract] [Full Text] [Related]

  • 15. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM, Hawley TS, Hawley RG, Qu CK.
    Oncogene; 2003 Sep 04; 22(38):5995-6004. PubMed ID: 12955078
    [Abstract] [Full Text] [Related]

  • 16. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
    Chen J, Yu WM, Bunting KD, Qu CK.
    Oncogene; 2004 Apr 29; 23(20):3659-69. PubMed ID: 15116097
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G, Yu-Lee L.
    J Biol Chem; 1997 Oct 24; 272(43):26841-9. PubMed ID: 9341115
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB.
    Am J Physiol Renal Physiol; 2004 Apr 24; 286(4):F653-9. PubMed ID: 14678947
    [Abstract] [Full Text] [Related]

  • 19. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
    Hackett RH, Wang YD, Sweitzer S, Feldman G, Wood WI, Larner AC.
    J Biol Chem; 1997 Apr 25; 272(17):11128-32. PubMed ID: 9111009
    [Abstract] [Full Text] [Related]

  • 20. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
    Gouilleux F, Wakao H, Mundt M, Groner B.
    EMBO J; 1994 Sep 15; 13(18):4361-9. PubMed ID: 7925280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.